We are international
Donate
TEXT SIZE   


THE INTERNATIONAL MYELOMA FOUNDATION ANNOUNCES BREAKTHROUGH AGREEMENT WITH CHINA TO SUPPORT MYELOMA TREATMENT, INFORMATION AND RESEARCH
Agreement with Chinese Health Promotion Foundation (an Arm of the Ministry of Health) to Be Signed at Ceremony in Beijing
09.08.10

–Agreement with Chinese Health Promotion Foundation (an Arm of the Ministry of Health) to Be Signed at Ceremony in Beijing–

North Hollywood, CA, and Beijing, CHINA - September 8, 2010 – The International Myeloma Foundation (IMF), the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today announced plans to sign a cooperative agreement with the Chinese Health Promotion Foundation (CHPF), an agency that operates under the Chinese Ministry of Health, to promote awareness of myeloma in China and to encourage measures to prevent and combat the disease. This groundbreaking agreement substantially expands the IMF's presence in Asia and will support the thousands of myeloma patients in China. The agreement will be signed at a ceremony September 9th in Beijing.

"Chinese health authorities clearly recognize the significance of myeloma in their country, and we are honored and gratified that they acknowledge the role the IMF can play in supporting patients, disseminating information and encouraging research," said Susie Novis, President and Co-Founder of the IMF.

On behalf of the CHPF, Dr. Zhao Yanling, Head of International Relations noted, "The mission of the CHPF is to bring together Chinese medical experts to raise the health standard of the Chinese people, and we can think of no better partner to work with us on behalf of myeloma patients than the IMF."

Myeloma, also called multiple myeloma, is a cancer of cells in the bone marrow that affect blood cell production and can damage bone. Once a rare disease of the elderly, multiple myeloma is being diagnosed in growing numbers and in increasingly younger people.
Initial goals of the agreement include:

  • Developing a scientific advisory committee of Chinese myeloma experts
  • Compiling data about the incidence and costs of myeloma in China
  • Developing Chinese language materials about myeloma for distribution in print and via website

Longer-range goals of this joint effort include establishing a Myeloma Patient Society in China and hosting a regional conference on myeloma for health care experts in Asia.

The agreement will be signed by Dr. Shuzhong Bai, Chairman of the CHPF, and by Daniel Navid, Senior Global Analyst for the IMF. The ceremony will be hosted by Dr. Yingming Chang, Secretary General of the CHPF. Also attending the ceremony will be Dr.Xiaojun Huang, Chairman of the Chinese Hematology Association and Hemotology Society of the Chinese Medical Association, and Dr. Wenmin Chen, a member of the International Myeloma Working Group, an organization of international myeloma experts organized by the IMF. The ceremony will be held September 9th at 3 PM in Beijing (midnight in Los Angeles).

ABOUT THE INTERNATIONAL MYELOMA FOUNDATION
The International Myeloma Foundation is the oldest and largest myeloma organization, reaching more than 195,000 members in 113 countries worldwide. A 501 (c) 3 non-profit organization dedicated to improving the quality of life of myeloma patients and their families, the IMF focuses in four key areas: research, education, support, and advocacy. To date, the IMF has conducted more than 200 educational seminars worldwide, maintains a world-renowned hotline, and operates Bank on a Cure®, a unique gene bank to advance myeloma research. The IMF can be reached at (800) 452-CURE. The global website is www.myeloma.org.

MEDIA CONTACTS:
United States – Stephen Gendel +1 212 918-4655
Global – Daniel Navid +41 21 825 55 46


 related articles